Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Zynex Inc (ZYXI)

Zynex Inc (ZYXI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 263,048
  • Shares Outstanding, K 31,846
  • Annual Sales, $ 184,320 K
  • Annual Income, $ 9,730 K
  • EBIT $ 9 M
  • EBITDA $ 13 M
  • 60-Month Beta 0.53
  • Price/Sales 1.40
  • Price/Cash Flow 19.71
  • Price/Book 7.22

Options Overview Details

View History
  • Implied Volatility 94.08% ( +26.43%)
  • Historical Volatility 62.46%
  • IV Percentile 82%
  • IV Rank 35.30%
  • IV High 221.93% on 08/16/24
  • IV Low 24.32% on 12/14/23
  • Put/Call Vol Ratio 999.99
  • Today's Volume 2
  • Volume Avg (30-Day) 56
  • Put/Call OI Ratio 0.16
  • Today's Open Interest 446
  • Open Int (30-Day) 683

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate 0.09
  • Number of Estimates 1
  • High Estimate 0.09
  • Low Estimate 0.09
  • Prior Year 0.04
  • Growth Rate Est. (year over year) +125.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
7.70 +7.27%
on 11/20/24
9.42 -12.31%
on 10/25/24
-0.27 (-3.17%)
since 10/22/24
3-Month
7.46 +10.72%
on 10/11/24
9.42 -12.31%
on 10/25/24
+0.51 (+6.58%)
since 08/22/24
52-Week
7.15 +15.52%
on 08/14/24
13.77 -40.01%
on 02/27/24
-0.82 (-9.03%)
since 11/22/23

Most Recent Stories

More News
Why Zynex Plunged Today

Earnings and guidance disappointed, but the pullback could be an opportunity.

ZYXI : 8.26 (+1.85%)
Zynex Recognized in Top 100 Healthcare Technologies Companies for Second Year in a Row

/PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices...

ZYXI : 8.26 (+1.85%)
Zynex, Inc Sets Third Quarter 2023 Earnings Call

/PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices...

ZYXI : 8.26 (+1.85%)
Zynex to Present at the Cantor Global Healthcare Conference

/PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices...

ZYXI : 8.26 (+1.85%)
Zynex Announces Share Repurchase Program

/PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices...

ZYXI : 8.26 (+1.85%)
Zynex to Present at the H.C. Wainwright Global Investment Conference

/PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices...

ZYXI : 8.26 (+1.85%)
Zynex Announces 1 Millionth Patient Milestone

/PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices...

ZYXI : 8.26 (+1.85%)
Zynex, Inc Announces New Therapy Products

/PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices...

ZYXI : 8.26 (+1.85%)
Zynex, Inc Founder and CEO Thomas Sandgaard to participate in Benzinga's Pharma Companies vs. A Tough Macro Backdrop Free Webinar on August 3rd at 12:15 PM ET

/PRNewswire/ -- Zynex, Inc. (Nasdaq: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices...

ZYXI : 8.26 (+1.85%)
Zynex Reports Second Quarter 2023 Financial Results

/PRNewswire/ -- Zynex, Inc. (Nasdaq: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices...

ZYXI : 8.26 (+1.85%)

Business Summary

Zynex, Inc. engineers, manufactures, markets, and sells medical devices for the electrotherapy, and stroke and spinal cord injury rehabilitation markets primarily in the United States. The company primarily offers electrotherapy products for pain relief and pain management; and NeuroMove for stroke and...

See More

Key Turning Points

3rd Resistance Point 8.51
2nd Resistance Point 8.40
1st Resistance Point 8.33
Last Price 8.26
1st Support Level 8.16
2nd Support Level 8.05
3rd Support Level 7.98

See More

52-Week High 13.77
Fibonacci 61.8% 11.24
Fibonacci 50% 10.46
Fibonacci 38.2% 9.68
Last Price 8.26
52-Week Low 7.15

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar